Out-of-Pocket Costs in Alopecia Areata: A Cross-Sectional Study in German-speaking Countries.


Journal

Acta dermato-venereologica
ISSN: 1651-2057
Titre abrégé: Acta Derm Venereol
Pays: Sweden
ID NLM: 0370310

Informations de publication

Date de publication:
04 Jan 2023
Historique:
received: 08 08 2022
accepted: 26 10 2022
entrez: 4 1 2023
pubmed: 5 1 2023
medline: 7 1 2023
Statut: epublish

Résumé

Alopecia areata is a common skin disease which is associated with psychosocial and financial burden. No curative therapy exists and, hence, affected persons resort to self-financed cosmetic solutions. However, studies on the economic impact of alopecia areata on individuals are limited. To estimate annual individual out-of-pocket costs in persons with alopecia areata, a cross-sectional study using a standardized online questionnaire was performed in Germany, Austria and Switzerland. A total of 346 individuals (95.1% women, mean age: 38.5 ± 11.6 years) with alopecia areata participated between April and August 2020. Mean additional spending on everyday necessities was 1,248€ per person per year, which was significantly influenced by the duration of the illness, the treatment provider, and disease severity. Hair replacement products and cosmetics accounted for the highest monthly costs, followed by costs for physician visits, hospital treatments, and medication. Most participants (n = 255, 73.7%) were currently not undergoing treatment, due to lack of efficacy, side-effects, costs and acceptance of the disease. Sex differences in expenses were observed, with women having higher expenditures. Alopecia areata-related out-of-pocket costs place a considerable financial burden on affected individuals, are higher compared with those of other chronic diseases, and should be considered in economic assessments of the impact of this disease.

Identifiants

pubmed: 36598280
doi: 10.2340/actadv.v103.4441
pmc: PMC9885285
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

adv00838

Références

Br J Dermatol. 2019 Jun;180(6):1377-1389
pubmed: 30501016
JAMA Dermatol. 2019 Apr 1;155(4):493-494
pubmed: 30810706
An Bras Dermatol. 2018 Sep-Oct;93(5):651-658
pubmed: 30156613
BMJ. 2005 Oct 22;331(7522):951-3
pubmed: 16239692
Lancet. 2019 Jan 26;393(10169):318-319
pubmed: 30696569
Clin Cosmet Investig Dermatol. 2015 Jul 24;8:397-403
pubmed: 26244028
Int J Trichology. 2020 Sep-Oct;12(5):197-204
pubmed: 33531741
J Am Acad Dermatol. 1993 Oct;29(4):568-75
pubmed: 8408792
J Eur Acad Dermatol Venereol. 2018 Jan;32(1):174-180
pubmed: 28857297
Am J Clin Dermatol. 2019 Apr;20(2):195-200
pubmed: 30390206
J Investig Dermatol Symp Proc. 2013 Dec;16(1):S13-5
pubmed: 24326541
J Am Acad Dermatol. 2018 Jan;78(1):15-24
pubmed: 29241773
Z Rheumatol. 2004 Oct;63(5):414-24
pubmed: 15517302
Acta Derm Venereol. 2019 Mar 1;99(3):263-267
pubmed: 30521060
J Am Acad Dermatol. 2006 Sep;55(3):438-41
pubmed: 16908349
Adv Ther. 2021 Sep;38(9):4646-4658
pubmed: 34292518
Int J Trichology. 2017 Oct-Dec;9(4):160-164
pubmed: 29118520
J Am Acad Dermatol. 2018 Jan;78(1):1-12
pubmed: 29241771
Front Psychiatry. 2019 Dec 17;10:864
pubmed: 31920737
J Eur Acad Dermatol Venereol. 2019 May;33(5):850-856
pubmed: 30762909
Br J Dermatol. 2012 May;166(5):916-26
pubmed: 22524397
J Investig Dermatol Symp Proc. 2020 Nov;20(1):S62-S68
pubmed: 33099390
Ann Rheum Dis. 2006 Sep;65(9):1175-83
pubmed: 16540552
Int J Environ Res Public Health. 2021 Jul 23;18(15):
pubmed: 34360117
Body Image. 2009 Jun;6(3):194-200
pubmed: 19409867
Am J Clin Dermatol. 2010;11(1):11-20
pubmed: 20000871
J Dtsch Dermatol Ges. 2020 Dec;18(12):1357-1368
pubmed: 33015951
Arch Dermatol. 1992 May;128(5):702
pubmed: 1575541
J Invest Dermatol. 2014 Apr;134(4):1141-1142
pubmed: 24202232
J Am Acad Dermatol. 2023 Jan;88(1):131-143
pubmed: 31870916
BMJ Open. 2017 May 4;7(4):e015468
pubmed: 28473521
Br J Dermatol. 2009 May;160(5):1034-9
pubmed: 19183424
Nat Rev Dis Primers. 2017 Mar 16;3:17011
pubmed: 28300084
J Am Acad Dermatol. 2018 Apr;78(4):832-834
pubmed: 29548423
Can Fam Physician. 2000 Jul;46:1469-77
pubmed: 10925761

Auteurs

Johaina Kullab (J)

Department of Dermatology and Allergy, Technical University of Munich, School of Medicine, Munich, Germany.

Maximilian C Schielein (MC)

Department of Dermatology and Allergy, Technical University of Munich, School of Medicine, Munich, Germany.

Caroline F Z Stuhlmann (CFZ)

The Graduate Center & Hunter College, City University of New York, Department of Psychology, New York, NY, USA; German Center for Health Services Research in Dermatology, Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Linda Tizek (L)

Department of Dermatology and Allergy, Technical University of Munich, School of Medicine, Munich, Germany.

Hannah Wecker (H)

Department of Dermatology and Allergy, Technical University of Munich, School of Medicine, Munich, Germany.

Alphina Kain (A)

Department of Dermatology and Allergy, Technical University of Munich, School of Medicine, Munich, Germany.

Tilo Biedermann (T)

Department of Dermatology and Allergy, Technical University of Munich, School of Medicine, Munich, Germany.

Alexander Zink (A)

Department of Dermatology and Allergy, Technical University of Munich, School of Medicine, Munich, Germany; Division of Dermatology and Venereology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. alexander.zink@tum.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH